Autism Calming and Soothing Balm by OLFC's Dr. V. Ruth

New Post Public Reply Private Reply Replies (0) Message Board
MoneyMaker
Autism Calming and Soothing Balm by OLFC's Dr. V. Ruth Pinney Is Realizing Its Vision of Helping Those With Autism

Autism Calming and Soothing Balm by OLFC's Dr. V. Ruth Pinney Is Realizing Its Vision of Helping Those With Autism
OLFC's New Autism Calming and Soothing Balm Is a Product Dedicated to Helping Individuals, Families, Therapists and Doctors Affected Working With Autism

PHILADELPHIA, PA--(Marketwired - Nov 21, 2013) -  Olfactory Biosciences Corp. (OTC Pink: OLFC), the maker of NOXO Autism Balm™, is pleased to announce today that they are receiving endorsements from a wide variety of individuals involved with Autism Spectrum Disorders. NOXO Autism Balm™ was created with one goal in mind and that was to provide relief to as many people affected by Autism as possible. OLFC is aware that NOXO Autism Balm™ will help select individuals affected by odor sensitivities. OLFC has been able to identify that individuals with odor sensitivities can be helped by blocking the odor from being smelled, as well as, providing other proprietary ingredients that have a calming and soothing affect. It is non-invasive and applied to the upper lip just below the nostrils for maximum effect.

"It does help with most people's perfumes, this was my biggest problem. I like the mild vanilla smell a lot. I re-apply it about 4 times a day. I would buy it again." -David L.

"NOXO smells great. It helps me to wear it when I am going to smelly places like the coffee shop or where a lot of people hang out and I am smelling too many things. Wearing the NOXO I don't smell much of anything." -Jeremy Sicile-Kira, coauthor of A Full Life with Autism, www.jeremysvision.com

"The balm worked great. My older son, who is 18, got upset last week. It's a very rare occurrence. I was glad to have the balm on hand and it worked!" -Ed Arranga - Co-founder & President, www.autismone.org

"This Balm worked wonders for my autistic grandson. Calms him within 5 minutes. Meltdowns are now few and far between. We just swipe this under his nose and WOW what a difference. - Sandra

"It helps my grandson with his eating and odors of certain foods. Has a really nice vanilla scent -- not strong at all. Great product and I highly recommend anyone who has an autistic child with feeding problems or needs in calming to at least try it. It is well worth the money. Better than taking drugs." -Doreen

Dr. Pinney states that what makes NOXO's Autism Balm™ unique is that it "is a simple, but powerful way to 'tone down' their overwhelming perceptions. The Autism Balm works well with most children that have Autism Spectrum Disorders (ASD). It is successful because it targets sensitivities naturally, changing the child's perception to sensory inputs in a direct, safe way!"

You can get more information on NOXO Autism balm™ at www.noxoinfo.com/autism.html

About Olfactory Biosciences Corp (http://www.noxoinfo.com/investor)

Olfactory Biosciences Corp.'s NOXO division is focused to develop a variety of products targeting Olfactory Receptors for the desired effect. These alternative medicine wellness products may modify behavior or provide relief to common behavior challenges such as anxiety, smoking or weight control, as examples.

FORWARD-LOOKING STATEMENTS

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: Statements by the Company, statements regarding the NOXO product line, optimism related to the business, expanding ales and other statements in this press release are forward-looking statements within the meaning of the Securities Litigation Reform Act of 1995. Such statements are based on current expectations, estimates and projections about the Company's business. Words such as expects, anticipates, intends, plans, believes, sees, estimates and variations of such words and similar expressions are intended to identify such forward-looking statements. These statements are not guarantees of future performance and involve certain risks and uncertainties that are difficult to predict. Actual results could vary materially from the description contained herein due to many factors including continued market acceptance of the Company's products or the need to raise additional capital. In addition, actual results could vary materially based on changes or slower growth in the indoor garden market; the potential inability to realize expected benefits and synergies; domestic and international business and economic conditions; changes in customer demand or ordering patterns; changes in the competitive environment including pricing pressures or technological changes; technological advances; shortages of manufacturing capacity; future production variables impacting excess inventory and other risk factors listed from time to time in the Company's Securities and Exchange Commission (SEC) filings under "risk factors" and elsewhere. The forward-looking statements contained in this press release speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this press release.

Richard Stevenson
President
Olfactory Biosciences Corp.
333 E. Lancaster Ave. Suite 317
Wynnewood, PA 19096, USA
Phone: 484-278-1626

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Borr Drilling's Rig Sinks, Uncertainty Looms Offshore

Updated Category News Views 228

Unexpected Turn of Events at Sea Now here's a gut-punch nobody saw coming. Borr Drilling Limited (NYSE and OSE: BORR) got hit hard when their Prospector 5 drilling rig went under the waves offshore Gabon. This ain't no desk job dilemma; we're talking about a real-life offshore catastrophe. It all went down on October 24, 2026, when the rig experienced a punch through...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 124

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 90

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 531

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 110

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Fluence Energy Hits Legal Snag: Investors Called to Act

Updated Category News Views 205

Fluence Energy Faces a Securities Fraud Challenge It's like watching a slow-motion train wreck. Fluence Energy, Inc. (NASDAQ: FLNC) now finds itself in the crosshairs of a securities fraud class action lawsuit. Apparently, someone was playing fast and loose with the truth concerning their financial guidance. The period in question stretches from November 24, 2025, to...

Continue Reading
Vantrue's Black Friday Dash Cam Deals: Save up to 44%

Updated Category News Views 162

Kicking Off Early Black Friday with Dash Cam Bargains In a bid to stay ahead of the holiday shopping rush, Vantrue announced its early Black Friday campaign with a range of discounts designed to capture the interest of road warriors and casual drivers alike. From November 1 to November 21, 2026, Vantrue is inviting bargain hunters to explore their offerings—culminating...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 202

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 218

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading

Top 5 Most Recently Viewed Articles

Grand Circle Cruise Line Achieves Top Honors for 2025 Travel

Updated Category News Views 271

Grand Circle Cruise Line Recognized Among the Best Grand Circle Cruise Line (GCCL) recently earned the impressive title of #2 Best River Cruise Line in the Travel + Leisure's 2025 World's Best Awards. This accolade showcases the hard work and dedication of the teams and crew members who make each journey remarkable along Europe’s scenic rivers. Celebrating a Special...

Continue Reading
Lancaster Resources Achieves License Approval for Gold Project Exploration

Updated Category News Views 145

Lancaster Resources Secures Approval for Exploration License Vancouver-based Lancaster Resources Inc. (CSE:LCR) (OTC:LANRF) (FRA:6UF0) is pleased to announce a significant milestone in its gold exploration journey. The company has received confirmation of an Exploration License for the Lake Cargelligo Gold Project from the State of New South Wales. Covering an impressive...

Continue Reading
Future of Vitrectomy Devices: Growth Insights and Trends

Updated Category News Views 93

Understanding the Vitrectomy Devices Market Growth The vitrectomy devices industry has become increasingly vital in treating various eye-related disorders, with significant growth projected in the coming years. By focusing on technological advancements and heightened awareness of eye health, the market is set to expand impressively. According to a recent report, the...

Continue Reading
Exploring RDG Mining's Innovative Cloud Mining Solution

Updated Category News Views 158

Understanding RDG Mining's Latest Offerings In recent times, the popularity of cryptocurrency has surged significantly, with platforms like RDG Mining capitalizing on this trend. RDG Mining is a leading cloud mining service based in the UK that has captured the interest of over 7.5 million users globally, particularly with the rise in various cryptocurrencies, including...

Continue Reading
Pharma Equity Group Updates Its Financial Reporting Strategy

Updated Category News Views 82

Revisions to Financial Reporting and Calendar The board of Pharma Equity Group A/S has recently made the strategic decision to submit only half-yearly financial reports moving forward. This adjustment reflects a shift in focus towards more impactful reporting. As a result, the financial calendar for 2025 has been updated to better align with these new reporting practices....

Continue Reading